Plaque Psoriasis Study in Pediatric Subjects
Public ClinicalTrials.gov record NCT02186665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double Blind, Parallel Group, Vehicle Controlled, Study of the Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 8 Weeks in Pediatric Subjects (2 to 12 Years of Age) With Mild to Moderate Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety, efficacy and calcium metabolism of up to 8 weeks of treatment with calcitriol 3 mcg/g ointment versus its vehicle, when used twice daily, without occlusion, to treat children aged 2 to 12 years, with plaque psoriasis.
Study identification
- NCT ID
- NCT02186665
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 19 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2014 (Type not available)
- Primary completion
- Nov 2015 (Actual)
- Completion
- Jan 2016 (Actual)
- Last update posted
- Feb 18, 2021
2014 – 2016
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| David Stoll, MD | Beverly Hills | California | 90212 | — |
| Center for Dermatology and Laser Surgery | Sacramento | California | 95819 | — |
| Dermatology Specialists Research | Louisville | Kentucky | 40202 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| RCMC Center for Dermatology at Linden Oaks | Rochester | New York | 14625 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Dermatology and Laser Center of Charleston | Charleston | South Carolina | 29414 | — |
| DermResearch | Austin | Texas | 78759 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Clinical Trials of Texas | San Antonio | Texas | 78229 | — |
| Jordan Valley Dermatology | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02186665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02186665 live on ClinicalTrials.gov.